The single-crystal X-ray diffraction structure of the sodium salt of N- (3-(aminosulfonyl)-4-chloro-2-hydroxyphenyl)-N′- (2,3-dichlorophenyl) urea at 173 K is reported. The structure contains 3 mol of water situated in distinct channels in the vicinity of the sodium cation. Powders of this phase undergo isomorphic dehydration, losing 0.5% w/w water between 90 and 15% relative humidity (RH) at 25 °C without changing the powder X-ray pattern. Below 15% RH and above 50 °C, additional dehydration occurs in conjunction with a reversible phase transition. A third semicrystalline dehydrated phase appears after vacuum-drying and at high temperatures and also can be reversibly rehydrated to the original form. Single crystals of the dehydrated phases could not be prepared, so a combination of methods were used to understand the structural changes occurring during the desolvation process, including thermal analysis, vapor sorption measurements, variable-humidity and variable-temperature powder X-ray diffraction, vibrational spectroscopy, and 1 H, 13 C, 15 N, and 23 Na magic-angle spinning (MAS) solid-state NMR. The uptake of water vapor into the trihydrate form was investigated by NMR and vibrational spectroscopy using isotopically labeled water. Static 2 H and 17 O NMR quadrupolar line shape analysis combined with changes in MAS spectra showed exchanged sites on the parent and water molecules. The results indicate that two moles of ion-associated water in the larger tunnel are more labile than a hydrogen-bonded mole of water. Entire water molecules can exchange into the lattice to a small extent, but more efficient hydrogen transfer exchange is observed in the main channel and a smaller perpendicular side channel. The exchanged water deuterons execute rapid three-site jump motions at 273 K.

Processing procedures for inducing domain size reduction and/or amorphous phase generation can be crucial for enhancing the bioavailability of active pharmaceutical ingredients (APIs). It is important to quantify these reduced coherence phases and to detect and characterize associated structural changes, to ensure that no deleterious effects on safety, function, or stability occur. Here, X-ray powder diffraction (XRPD), total scattering pair distribution function (TSPDF) analysis, and solid-state nuclear magnetic resonance spectroscopy (SSNMR) have been performed on samples of GSK2838232B, an investigational drug for the treatment of human immunodeficiency virus (HIV). Preparations were obtained through different mechanical treatments resulting in varying extents of domain size reduction and amorphous phase generation. Completely amorphous formulations could be prepared by milling and microfluidic injection processes. Microfluidic injection was shown to result in a different local structure due to dispersion with dichloromethane (DCM). Implications of combined TSPDF and SSNMR studies to characterize molecular compounds are also discussed, in particular, the possibility to obtain a thorough structural understanding of disordered samples from different processes.

No abstract

No abstract